Summary
50 / 100 · Bulios Score
What speaks for it
- Revenue grew by 22% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
- It bought back its own shares for $17.2M in the last fiscal year, 5.3% of its market value.
What to watch
- It pays out more in dividends than it earns: 517% of profit.
- It missed profit estimates 6 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 25.2 USD for 1 USD of yearly profit. Over the last five years it was 10.4 USD on average.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 42% a year over 5 years. Over the last 3 years it grew by 22% a year.
Growth in detailDoes it make money?
ReasonablyOver the last 12 months it made a loss of $10.6M.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 20.53%
- Paid out of profit
- 517%
- Raised in a row
- 2 years
You receive $1.36 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Mildly negative- Buy 0
- Hold 0
- Sell 1
Today's price within the analysts' price targets
The average target of $6.5 is 3.4% above today's price. 0.0% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.